Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer - Wikidata - wikimedia - TriplyDB

Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer

Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer

http://www.wikidata.org/entity/Q34909724

about

OCT4 Expression Enhances Features of Cancer Stem Cells in a Mouse Model of Breast Cancer MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA Mechanistic basis and clinical relevance of the role of transforming growth factor-β in cancer Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model Metastasis: a therapeutic target for cancer.Targeting the transforming growth factor-beta signaling pathway in human cancer.Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.Expression of ALDH1 and TGFβ2 in benign and malignant breast tumors and their prognostic implications Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients.Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.LncRNA-HIT Functions as an Epigenetic Regulator of Chondrogenesis through Its Recruitment of p100/CBP Complexes.Abrogation of TGFbeta signaling induces apoptosis through the modulation of MAP kinase pathways in breast cancer cells.Gr-1+CD11b+ cells are responsible for tumor promoting effect of TGF-β in breast cancer progression Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction.Targeting the TGFβ signalling pathway in disease.Role of transforming growth factor-beta in cancer progression.Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17 An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments.Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells Combating immunosuppression in glioma Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?Silencing of atp6v1c1 prevents breast cancer growth and bone metastasis.Escin Ia suppresses the metastasis of triple-negative breast cancer by inhibiting epithelial-mesenchymal transition via down-regulating LOXL2 expression Acute wounds accelerate tumorigenesis by a T cell-dependent mechanism.The polarization of immune cells in the tumour environment by TGFbeta.Role of TGF-β in breast cancer bone metastases.Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers Prognostic significance of PLIN1 expression in human breast cancer.TGF-β in the Bone Microenvironment: Role in Breast Cancer Metastases.Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update.Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer.Bone-derived soluble factors and laminin-511 cooperate to promote migration, invasion and survival of bone-metastatic breast tumor cells.Dysadherin expression promotes the motility and survival of human breast cancer cells by AKT activation.Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.

P2860

Q24627533-8895BED5-EFCE-40E1-B5CF-CAB97F83BD01 Q24648090-164412CF-847F-4FC8-96FF-1EFF72FBCF66 Q26771386-A5C59187-C7E0-41E7-A6E7-8390320FD7AB Q27325140-0942F08C-8B7C-4A86-BED0-228605E041BE Q27334832-08B6756F-8D2C-465C-B88E-D4D40D3727E9 Q28547327-036DA6A5-06E1-47B4-938C-DEAA324DDE21 Q30439221-3E675ABD-26FE-4C29-A140-1D9ECE8DBAC0 Q33517772-F93135A3-6351-4527-86BD-92CA214EC1D9 Q33933880-26EF544D-59AB-42D9-9FEF-A13272961A83 Q34029177-4CC85BBA-99E4-43CE-BAE1-CE4BF137027F Q34163525-6E4DA177-E975-4D1B-B690-2148B994F004 Q34465050-02CA8862-62EC-4A46-9F73-C4C4E24794E3 Q34655823-D788D58F-2C3B-49FF-8422-BB6CF1357F59 Q35172618-44FCCFD8-1BFC-47C4-A27C-568D499346BA Q35490960-F423B09C-1054-43B7-9927-D18483DF881C Q35859901-937841C0-516B-4F24-A305-D01D171FB9A1 Q35867458-7A41AF53-F422-46A6-A6A2-8EB74DE2BAD4 Q36207817-7E49DBA0-568E-4824-BB91-2631FDACE3AF Q36439970-7795A60A-A924-4BD1-8EEA-BF0AFCB8CF2B Q36462348-CCACEE02-F073-48BB-95C5-7CA2368A3911 Q36677493-0E3A4C5F-4E07-4487-917D-72893C92A09B Q36738895-B5F7EA41-7AE0-4F16-99DE-71B5D187E452 Q36981811-0E2A1CCE-3082-4FF6-9BEE-19B19FAFFB5D Q36983438-AE7E47D2-2B46-4C7A-B93A-9580EA42CE2A Q37152195-368B80F4-0A37-4020-AF00-6ED18FF434DD Q37179415-A99EEDE1-D76C-445D-9120-F1F321F0405A Q37219226-E4287AF2-42FA-4787-8AC7-D36114F17DDC Q37249049-6D9BA25F-EC24-415C-91D8-E1FFE6011CB6 Q37269104-656638C4-0E22-4C2E-B2A4-6EAAA81D2A74 Q37398730-36C763D1-EA56-4E55-B837-6D0F7DF24046 Q37454364-5BECFC9D-B88C-4AC6-9DFD-7F78E059D7AB Q37591417-018E8328-9024-4424-A238-D5BD4D7B2A89 Q37625382-297A2F80-1E39-406A-898D-0FDA6727800E Q37688087-67B1715E-B9E3-4FCD-95E9-82E737DB7640 Q37900199-ACD341B9-1DA2-4841-A9CC-0ED104682D98 Q37918451-656F099B-EBE7-4E47-AA89-62E01B3C8FB7 Q38988997-E3D4E85B-F00A-4FF3-A7AD-028675B8C272 Q39018130-017AC52C-5D5A-4A9E-A73D-6199AB107377 Q39365972-E5090B9A-7EA3-4B1E-9DA8-C17E8B26CE10 Q39771195-7A3830E6-AD5D-4EF2-9EAC-0145B7F3DF6A

P2860

Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer

http://www.wikidata.org/entity/Q34909724

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Bone sialoprotein mediates the ...... a mouse model of breast cancer

@ast

Bone sialoprotein mediates the ...... a mouse model of breast cancer

@en

Bone sialoprotein mediates the ...... a mouse model of breast cancer

@nl

type

label

Bone sialoprotein mediates the ...... a mouse model of breast cancer

@ast

Bone sialoprotein mediates the ...... a mouse model of breast cancer

@en

Bone sialoprotein mediates the ...... a mouse model of breast cancer

@nl

prefLabel

Bone sialoprotein mediates the ...... a mouse model of breast cancer

@ast

Bone sialoprotein mediates the ...... a mouse model of breast cancer

@en

Bone sialoprotein mediates the ...... a mouse model of breast cancer

@nl

P1433

Q34909724-75227B8B-F70E-43FB-BDB8-A6993CF06477

P1476

Q34909724-69F870A0-6FB7-425A-AA91-1493ACB6A14C

P2093

Q34909724-04107B73-6711-4E25-9C93-D93A8688394F

Q34909724-0A7EA940-588D-432A-928E-9FCDF7013E37

Q34909724-349D8DD3-A0E4-4D0A-A3F3-130EB05EDAE2

Q34909724-5527D4B8-1FE0-4D34-B303-9D58788B0890

Q34909724-81C38C85-FF72-4EEF-B74D-891208206ABD

Q34909724-8CE04AB4-56C4-4B70-A16F-BA2CBD5AA7A4

Q34909724-A6160A8A-4A48-43EF-9202-6CCD60693AAF

Q34909724-ABA28E29-85D6-49A1-B34D-860DE279AE34

Q34909724-C5B1AB2E-4FB6-42A2-8588-18D4218F2FBA

Q34909724-D21D21D5-082F-419E-8622-754777D16B38

P2860

Q34909724-02766FAE-CD91-4B97-AF10-CCD4EBA25606

Q34909724-06F35AB8-BE33-4936-9BE5-3A3073E86AD2

Q34909724-0A3271DA-16B9-4722-B399-D816EB02685F

Q34909724-10FCFDA7-EA9B-4D5A-93D3-D73086C2FFD6

Q34909724-1B6C26F3-741F-4654-8C80-3B928D8BC472

Q34909724-1D2501F8-E34E-4654-BE5A-DA2F37892736

Q34909724-1F5E5B7A-8E4A-4C16-B78B-40799296B753

Q34909724-2713907E-9112-46CC-9B95-0A7F9E7813DA

Q34909724-2D004AE8-B717-4615-BC08-A790125C9E52

Q34909724-2DFD859C-D44C-487E-9ED4-34163FAADA22

P304

Q34909724-1D2B9003-885F-4EB5-9DE7-13DEBE0A7564

P31

Q34909724-B8221ADB-6CDB-4240-9042-B52CD68D90D3

P356

Q34909724-A8FAEDDC-355E-43B2-A504-2A4FF51B67ED

P407

Q34909724-729DF54D-0880-45C7-874D-915DC6C22CF3

P433

Q34909724-3BD5757B-AF72-4659-8892-F3CE5C76ACE1

P478

Q34909724-DA57CE4C-48EC-481E-A2F5-62DD2AE71A1A

P50

Q34909724-DC133608-40DE-4615-A788-A4AE3C219DF8

Q34909724-E1474625-71FF-4AAC-AB6A-18C5861146D8

P577

Q34909724-5A8CBBBB-D26A-44EE-A92D-C65611C4BB03

P5875

Q34909724-11F2069A-290D-4782-8300-B1698534AE01

P698

Q34909724-631C96AE-695A-4308-A0F5-456E9313CD39

P932

Q34909724-864954EA-F837-49FC-962F-E70AD4B63E00

P356

0008-5472.CAN-06-0068

P1433

Cancer Research

P1476

Bone sialoprotein mediates the ...... a mouse model of breast cancer

@en

P2093

Adam M Suchar

http://www.w3.org/2001/XMLSchema#string

Aleksandra M Michalowska

http://www.w3.org/2001/XMLSchema#string

Alka Jain

http://www.w3.org/2001/XMLSchema#string

Binwu Tang

http://www.w3.org/2001/XMLSchema#string

Jan Pinkas

http://www.w3.org/2001/XMLSchema#string

Jeong-Seok Nam

http://www.w3.org/2001/XMLSchema#string

Larry W Fisher

http://www.w3.org/2001/XMLSchema#string

Mi-Jin Kang

http://www.w3.org/2001/XMLSchema#string

Neal S Fedarko

http://www.w3.org/2001/XMLSchema#string

Scott Lonning

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin

Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack

Osteopontin: role in cell signaling and cancer progression

A multigenic program mediating breast cancer metastasis to bone

TGF-beta signaling in tumor suppression and cancer progression

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.

TGF-beta signaling: positive and negative effects on tumorigenesis.

P304

6327-6335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-06-0068

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Christina H Stuelten

Lalage M Wakefield

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7005945

http://www.w3.org/2001/XMLSchema#string

P698

16778210

http://www.w3.org/2001/XMLSchema#string

P932

1528715

http://www.w3.org/2001/XMLSchema#string